newsfilter
← Latest News
GlobeNewswire·

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call pointTransaction is expected to be accretive to 2024 earningsEstimated peak